Specific real-time PCR vs. fluorescent dyes for serum free DNA quantification

被引:19
作者
Chiminqgi, Mihelaiti
Moutereau, Stephane
Pernet, Pascal
Conti, Marc
Barbu, Veronique
Lemant, Jerome
Sacko, Mory
Vaubourdolle, Michel
Loric, Sylvain
机构
[1] Henri Mondor Univ Hosp, AP HP, Creteil, France
[2] St Antoine Univ Hosp, AP HP, Clin Biochem Lab A, Paris, France
[3] Bicetre Univ Hosp, AP HP, Le Kremlin Bicetre, France
[4] St Antoine Univ Hosp, AP HP, Clin Biochem Lab B, Paris, France
[5] Lariboisiere Univ Hosp, AP HP, Creteil, France
[6] BioQuanta Corp, Aurora, CO USA
关键词
circulating DNA; DNA quantification; PicoGreen; quantitative PCR;
D O I
10.1515/CCLM.2007.191
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Detecting and quantifying circulating free DNA in patient serum has become a major challenge. New methods using conventional or automated DNA amplification have been developed. As quantitative real-time PCR (QPCR) remains expensive and requires dedicated automated instrumentation, we questioned whether simple quantification using fluorescent dyes is efficient for determination of free DNA levels in serum. Methods: Serum samples from 180 cancer patients and 58 healthy volunteers were used for DNA quantification according to three methods: (i) using an exonic part of the P-globin gene as the amplifying target; (ii) amplifying a 105-bp intron 1 part of the housekeeping cyclophilin A gene, both referring to specific standard curves; and (iii) using a PicoGreen DNA quantification kit without amplification. Results: The 58 samples from healthy controls showed a reference limit of (95th percentile) < 160 cyclophilin gene copies/mL. The 180 cancer samples displayed values ranging between 300 and 215,000 copies/mL. The cyclophilin method showed a high level of correlation with both the P-globin (r = 0.911, p < 0.0001) and PicoGreen (r=0.915, p < 0.0001) methods. Conclusions: Aside from the disadvantage that the QPCR assays can only be used in clinical biochemistry laboratories that possess QPCR apparatus, the use of direct PicoGreen quantification displays major advantages in a routine context: it is less time-consuming and is quite inexpensive, but is still correlated with QPCR.
引用
收藏
页码:993 / 995
页数:3
相关论文
共 12 条
[1]  
Anker P, 2000, MEDICINA-BUENOS AIRE, V60, P699
[2]   Detection of mutated BRAFV600E variant in circulating DNA of stage III-IV melanoma patients [J].
Daniotti, Maria ;
Vallacchi, Viviana ;
Rivoltini, Licia ;
Patuzzo, Roberto ;
Santinami, Mario ;
Arienti, Flavio ;
Cutolo, Gianluca ;
Pierotti, Marco A. ;
Parmiani, Giorgio ;
Rodolfo, Monica .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (11) :2439-2444
[3]   Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance [J].
Gormally, Emmanuelle ;
Caboux, Elodie ;
Vineis, Paolo ;
Hainaut, Pierre .
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2007, 635 (2-3) :105-117
[4]   Performance of high-throughput DNA quantification methods [J].
Haque, KA ;
Pfeiffer, RM ;
Beerman, MB ;
Struewing, JP ;
Chanock, SJ ;
Bergen, AW .
BMC BIOTECHNOLOGY, 2003, 3 (1)
[5]  
Lo YMD, 2000, CLIN CHEM, V46, P319
[6]   Quantitative analysis of fetal DNA in maternal plasma and serum: Implications for noninvasive prenatal diagnosis [J].
Lo, YMD ;
Tein, MSC ;
Lau, TK ;
Haines, CJ ;
Leung, TN ;
Poon, PMK ;
Wainscoat, JS ;
Johnson, PJ ;
Chang, AMZ ;
Hjelm, NM .
AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (04) :768-775
[7]   Presence of fetal DNA in maternal plasma and serum [J].
Lo, YMD ;
Corbetta, N ;
Chamberlain, PF ;
Rai, V ;
Sargent, IL ;
Redman, CWG ;
Wainscoat, JS .
LANCET, 1997, 350 (9076) :485-487
[8]  
Rengarajan K, 2002, MOL VIS, V8, P416
[9]  
Stroun M, 2000, ANN NY ACAD SCI, V906, P161
[10]   ISOLATION AND CHARACTERIZATION OF DNA FROM THE PLASMA OF CANCER-PATIENTS [J].
STROUN, M ;
ANKER, P ;
LYAUTEY, J ;
LEDERREY, C ;
MAURICE, PA .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1987, 23 (06) :707-712